S100B and cancer: Although additional studies will be warranted to elucidate the molecular mechanisms that contribute to the angioinhibitory activity of Nef-M1 peptide, our results suggest that Nef-M1 peptide could be a potential drug lead compound for therapeutic applications for the treatment of cancers.